Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOSÂ® (pioglitazone HCI), ACTOplus metÂ® (pioglitazone HCl and metformin HCl) and duetactÂ® (pioglitazone HCl and glimepiride)